NF-kappaB Regulates Phagocytic NADPH Oxidase by Inducing the Expression of Gp91phox
Overview
Affiliations
The superoxide-generating phagocytic NADPH oxidase is an important component of the innate immune response against microbial agents, and is involved in shaping the cellular response to a variety of physiological and pathological signals. One of the downstream targets of NADPH oxidase-derived radicals is the ubiquitous transcription factor NF-kappaB, which controls the expression of a large array of genes involved in immune function and cell survival. Here we show that NF-kappaB itself is a key factor in controlling NADPH oxidase expression and function. In monocytic and microglial cell lines, the expression of the NADPH oxidase subunit gp91(phox) was induced by lipopolysaccharide/interferon gamma treatment and was inhibited in cells constitutively expressing IkappaBalpha. Furthermore, inducible reactive oxygen species production was inhibited in IkappaBalpha overexpressing cells. gp91(phox) expression was very low in RelA(-/-) fibroblasts and could be induced by reconstituting these cells with p65/RelA. Thus, gp91(phox) expression is dependent on the presence of p65/RelA. We also found that gp91(phox) transcription is dependent on NF-kappaB and we identified two potential cis-acting elements in the murine gp91(phox) promoter that control NF-kappaB-dependent regulation. The findings raise the possibility of a positive feedback loop in which NF-kappaB activation by oxidative stress leads to further radical production via NADPH oxidase.
Moreira R, Oliveira P, Spadella M, Ferreira R, Alves M Antioxidants (Basel). 2025; 14(2).
PMID: 40002337 PMC: 11851673. DOI: 10.3390/antiox14020150.
Schrier M, Smirnova M, Nemeth D, Deth R, Quan N J Inflamm Res. 2025; 18:681-699.
PMID: 39839188 PMC: 11748166. DOI: 10.2147/JIR.S501652.
Drugs repurposing in the experimental models of Alzheimer's disease.
Joodi S, Ibrahim W, Khattab M Inflammopharmacology. 2025; 33(1):195-214.
PMID: 39752040 PMC: 11799062. DOI: 10.1007/s10787-024-01608-7.
Wiens K, Brooks N, Riar I, Greuel B, Lindhout I, Klegeris A Molecules. 2024; 29(21).
PMID: 39519725 PMC: 11547910. DOI: 10.3390/molecules29215084.
Martinez-Torres A, Moran J CNS Neurosci Ther. 2024; 30(11):e70099.
PMID: 39496572 PMC: 11534500. DOI: 10.1111/cns.70099.